Download PDF
Dtsch Med Wochenschr 2021; 146(09): 591-597
DOI: 10.1055/a-1294-1155
Dossier

Wichtige Differenzialdiagnosen von Mon- und Oligoarthritiden

Diagnostic approach and differential diagnosis of mon- and oligoarthritis
Anna Kernder
,
Philipp Sewerin
› Further Information
Also available at
    Permissions and Reprints

Das Auftreten einer Arthritis in nur einem Gelenk (Monarthritis) sowie einer Oligoarthritis, welche 2–4 Gelenke betrifft, kann die initiale Manifestation verschiedenster Erkrankungen sein. In diesem Beitrag beleuchten wir die notwendige Diagnostik und die häufigsten Ursachen und geben darüber hinaus Hinweise zu den therapeutischen Optionen bei den jeweiligen Differenzialdiagnosen.

Abstract

Reasons of mon- and oligoarthritis are heterogeneous. The diagnostic approach includes a detailed medical anamnesis, physical examination and imaging (conventional X-ray, sonography, MRI and, CT). Analysis of the synovial fluid is required in suspected septic arthritis and frequently helps in diagnosis and differential diagnosis of crystal arthropathies. Dual-energy-CT (DECT) detects sodium urate crystals and can replace joint puncture in some cases. In addition to crystal arthropathies and septic arthritis, differential diagnosis of mon-/oligoarthritis includes reactive arthritis, arthrosis and monarthritic courses of SpA/PsA. A rheumatologist should be consulted particularly in the case of persistent monarthritides, in order to initiate a specific therapy to prevent secondary damage.

Schlüsselwörter

Monarthritis - Oligoarthritis - Synovialisanalyse

Key words

monarthritis - oligoarthritis - synovial fluid analysis


Publication History

Article published online:
30 April 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Ross JJ. Septic Arthritis of Native Joints. Infect Dis Clin North Am 2017; 31: 203-218
    CrossrefPubMedGoogle Scholar
  • 2 Choi HK, Niu J, Neogi T. et al. Nocturnal risk of gout attacks. Arthritis Rheumatol Hoboken NJ 2015; 67: 555-562
    CrossrefPubMedGoogle Scholar
  • 3 Maury EE, Flores RH. Acute monarthritis: diagnosis and management. Prim Care 2006; 33: 779-793
    CrossrefPubMedGoogle Scholar
  • 4 van Nies JAB, van Steenbergen HW, Krabben A. et al. Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis. Ann Rheum Dis 2015; 74: 883-889
    CrossrefPubMedGoogle Scholar
  • 5 Christiansen SN, Østergaard M, Terslev L. Ultrasonography in gout: utility in diagnosis and monitoring. Clin Exp Rheumatol 2018; 36 (Suppl. 114) 61-67
    PubMedGoogle Scholar
  • 6 Wakefield RJ, Gibbon WW, Conaghan PG. et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 2000; 43: 2762-2770
    CrossrefPubMedGoogle Scholar
  • 7 McQueen FM. Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2013; 27: 499-522
    CrossrefPubMedGoogle Scholar
  • 8 Hettenkofer HJ, Schneider M, Braun J. Rheumatologie Diagnostik-Klinik-Therapie. 6. Aufl. Stuttgart: Thieme; 2014
    Google Scholar
  • 9 Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol 2009; 36: 1287-1289
    CrossrefPubMedGoogle Scholar
  • 10 Kiltz U, Braun J. [S2e guidelines “Gouty arthritis – specialist”]. Z Rheumatol 2016; 75 (Suppl. 02) 9-10
    CrossrefPubMedGoogle Scholar
  • 11 Richette P, Doherty M, Pascual E. et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 2020; 79: 31-38
    CrossrefPubMedGoogle Scholar
  • 12 Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004; 51: 321-325
    CrossrefPubMedGoogle Scholar
  • 13 Jansen TL, Richette P, Perez-Ruiz F. et al. International position paper on febuxostat. Clin Rheumatol 2010; 29: 835-840
    CrossrefPubMedGoogle Scholar
  • 14 Gregoriano C, Ceschi A, Rauber-Lüthy C. et al. Acute thiopurine overdose: analysis of reports to a National Poison Centre 1995-2013. PloS One 2014; 9: e86390
    CrossrefPubMedGoogle Scholar
  • 15 Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol 2011; 23: 192-202
    CrossrefPubMedGoogle Scholar
  • 16 Zhang W, Doherty M, Bardin T. et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011; 70: 563-570
    CrossrefPubMedGoogle Scholar
  • 17 Zhang W, Doherty M, Pascual E. et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70: 571-575
    CrossrefPubMedGoogle Scholar
  • 18 García-Kutzbach A, Chacón-Súchite J, García-Ferrer H. et al. Reactive arthritis: update 2018. Clin Rheumatol 2018; 37: 869-874
    CrossrefPubMedGoogle Scholar
  • 19 Pennisi M, Perdue J, Roulston T. et al. An overview of reactive arthritis. JAAPA Off J Am Acad Physician Assist 2019; 32: 25-28
    CrossrefPubMedGoogle Scholar
  • 20 Fingerle V, Wilske B. [Stage-oriented treatment of Lyme borreliosis]. MMW Fortschr Med 2006; 148: 39-41
    PubMedGoogle Scholar